Knowledge Tree
Psychoactive tryptamines
Also known as: psychoactive tryptamine
Facts (15)
Sources
Effects of psychedelics on neurogenesis and broader neuroplasticity link.springer.com Dec 19, 2024 15 facts
claimPsychoactive tryptamines act as potent 5-HT2A agonists and often demonstrate affinity for 5-HT1 and other 5-HT2 receptors, as well as potential interactions with ionotropic and metabotropic glutamate receptors, dopamine, acetylcholine, and trace amine-associated receptors (TAAR) (Carbonaro and Gatch 2016).
claimPsychoactive tryptamines, including psilocybin, DMT, and ibogaine, enhance neuroplasticity by promoting the proliferation, migration, and differentiation of neurons.
claimPsychoactive tryptamines share a primary pharmacologic pathway of 5-HT2A receptor agonism, but can generate different experiences due to variable affinity for other receptors.
claimKetamine, harmala alkaloids, and certain psychoactive tryptamines promote the proliferation, differentiation, and survival of neurons in the adult brain, often through the upregulation of neurotrophic factors such as BDNF.
claimIbogaine is a naturally occurring psychoactive tryptamine found in certain plants of the Apocynaceae family native to Central Africa and has been investigated for its potential to mitigate drug-seeking behavior.
claimThe majority of studies on psychoactive tryptamines provide evidence that they have the potential to enhance aspects of neuroplasticity.
measurementA review of eleven studies on psychoactive tryptamines found that 18% investigated psilocybin, 9% investigated ibogaine, and 73% investigated DMT analogs, including ayahuasca.
claimClinical investigation of psychoactive tryptamines for the treatment of mood and drug abuse disorders began in the mid-20th century.
claimLow doses of psychoactive tryptamines facilitate fear extinction and improve behavioral outcomes in animal models of stress and depression.
claimPsychoactive tryptamines induce altered states of consciousness characterized by heightened introspection (de Araujo et al. 2012) and changes in sensory perception, mood, and thought (Calvey and Howells 2018).
claimPsychoactive tryptamines interact with multiple neurotransmission systems, including serotonin, glutamate, dopamine, and sigma-1 receptors, to produce a broad spectrum of effects.
claimFuture research into psychoactive tryptamines as therapeutic tools should prioritize modifying molecular structures, refining administration methods, and understanding drug interactions.
claimSome advocates proposed the systematic use of psychoactive tryptamines by healthy individuals to enhance cognition.
claimAncient civilizations globally have used psychoactive tryptamines for millennia.
claimTherapeutic development strategies for psychoactive tryptamines aim to modify the molecules to retain neuroplastic benefits while minimizing hallucinogenic side effects.